April 11, 2024 Comments Off on New patent for Glaxosmithkline drug ARNUITY ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…
Source
April 11, 2024 Comments Off on New patent expiration for Emd Serono drug MAVENCLAD Posted in: Uncategorized
Annual Drug Patent Expirations for MAVENCLAD Mavenclad is a drug marketed by Emd Serono Inc and is included in one NDA. It is available from one supplier. There are five…
Source
